NCT06309173View on ClinicalTrials.gov

Development of Digital Biomarkers in Multiple Sclerosis: Validation Study 2

Not yet recruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

January 31, 2026

Primary Completion Date

February 29, 2028

Study Completion Date

February 29, 2028

Conditions
Multiple Sclerosis
Trial Locations (3)

1090

Vienna Medical University, Department of Neurology, Vienna

6020

Innsbruck Medical University, Department of Neurology, Innsbruck

94158

University of California, San Francisco (UCSF) Weill Institute, Department of Neurology, San Francisco

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT06309173 - Development of Digital Biomarkers in Multiple Sclerosis: Validation Study 2 | Biotech Hunter | Biotech Hunter